About
Oncology Treatments
Areas of Focus
Categories
San Diego & Southern California
Team (14)
Athena Countouriotis
Athena Countouriotis, M.D.
Avenzo Therapeutics
team_member
Brian Sun
Brian Sun, M.S., J.D.
Avenzo Therapeutics
team_member
Carl Gordon
Carl Gordon, Ph.D., C.F.A.
Avenzo Therapeutics
team_member
Garry Nicholson
Garry Nicholson, M.B.A.
Avenzo Therapeutics
team_member
Homa Yeganegi
Homa Yeganegi
Avenzo Therapeutics
team_member
Jakob Dupont
Jakob Dupont, M.D., M.A.
Avenzo Therapeutics
team_member
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
1,595
By Phase
PHASE1/PHASE2: 4
By Status
RECRUITING: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07193511Lead Sponsor
Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
PHASE1/PHASE2Recruiting
355 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2030
NCT06998407Lead Sponsor
Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
PHASE1/PHASE2Recruiting
380 participants
Started: Aug 20, 2025 · Completed: Aug 31, 2030
NCT07038343Lead Sponsor
Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
PHASE1/PHASE2Recruiting
430 participants
Started: Jun 4, 2025 · Completed: Dec 31, 2030
NCT05867251Lead Sponsor
Study of AVZO-021 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
430 participants
Started: Aug 30, 2023 · Completed: Jan 31, 2030
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...